Global Nanoparticles - Metal & Metal Oxides Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Nanoparticles - Metal & Metal Oxides Market Research Report 2024
Metal nanoparticles are submicron scale entities made of pure metals (e.g., gold, platinum, silver, titanium, zinc, cerium, iron, and thallium) or their compounds (e.g., oxides, hydroxides, sulfides, phosphates, fluorides, and chlorides).
According to MRAResearch’s new survey, global Nanoparticles - Metal & Metal Oxides market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nanoparticles - Metal & Metal Oxides market research.
Key manufacturers engaged in the Nanoparticles - Metal & Metal Oxides industry include Pfizer Inc., Nanobiotix, NanoComposix, AstraZeneca, Merck KGaA, Immunolight LLC, Nanospectra Biosciences, Inc, Brigham and Women’s Hospital (BWH) and Celgene Corporation, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Nanoparticles - Metal & Metal Oxides were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nanoparticles - Metal & Metal Oxides market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Nanoparticles - Metal & Metal Oxides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Pfizer Inc.
Nanobiotix
NanoComposix
AstraZeneca
Merck KGaA
Immunolight LLC
Nanospectra Biosciences, Inc
Brigham and Women’s Hospital (BWH)
Celgene Corporation
CytImmune Sciences Inc.
Z-Medica LLC
US Research Nanomaterials
Reinste
NanoScale
American Elements
EPRUI Nanoparticles and Microspheres
Altairnano
Sigma-Aldrich
Access Business Group
Segment by Type
Gold Nanoparticles
Silver Nanoparticles
Iron Oxide Nanoparticles
Alumina Nanoparticles
Gadolinium Oxide Nanoparticles
Others
In-vivo Imaging
Targeted Drug Delivery
Proton Therapy
In-vitro Assays
Cell & Phantom Imaging
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Nanoparticles - Metal & Metal Oxides report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to MRAResearch’s new survey, global Nanoparticles - Metal & Metal Oxides market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nanoparticles - Metal & Metal Oxides market research.
Key manufacturers engaged in the Nanoparticles - Metal & Metal Oxides industry include Pfizer Inc., Nanobiotix, NanoComposix, AstraZeneca, Merck KGaA, Immunolight LLC, Nanospectra Biosciences, Inc, Brigham and Women’s Hospital (BWH) and Celgene Corporation, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Nanoparticles - Metal & Metal Oxides were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nanoparticles - Metal & Metal Oxides market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Nanoparticles - Metal & Metal Oxides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer Inc.
Nanobiotix
NanoComposix
AstraZeneca
Merck KGaA
Immunolight LLC
Nanospectra Biosciences, Inc
Brigham and Women’s Hospital (BWH)
Celgene Corporation
CytImmune Sciences Inc.
Z-Medica LLC
US Research Nanomaterials
Reinste
NanoScale
American Elements
EPRUI Nanoparticles and Microspheres
Altairnano
Sigma-Aldrich
Access Business Group
Segment by Type
Gold Nanoparticles
Silver Nanoparticles
Iron Oxide Nanoparticles
Alumina Nanoparticles
Gadolinium Oxide Nanoparticles
Others
Segment by Application
In-vivo Imaging
Targeted Drug Delivery
Proton Therapy
In-vitro Assays
Cell & Phantom Imaging
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Nanoparticles - Metal & Metal Oxides report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source